Compare ABEO & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABEO | SKYH |
|---|---|---|
| Founded | 1974 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.5M | 418.4M |
| IPO Year | 2005 | 2020 |
| Metric | ABEO | SKYH |
|---|---|---|
| Price | $5.97 | $10.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $20.00 | $13.13 |
| AVG Volume (30 Days) | ★ 1.5M | 186.9K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | 105.11 |
| EPS | N/A | ★ N/A |
| Revenue | $2,998,000.00 | ★ $27,540,000.00 |
| Revenue This Year | $1,024.31 | $78.89 |
| Revenue Next Year | $145.42 | $73.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 258.18 | 86.57 |
| 52 Week Low | $4.00 | $8.22 |
| 52 Week High | $7.65 | $11.70 |
| Indicator | ABEO | SKYH |
|---|---|---|
| Relative Strength Index (RSI) | 41.86 | 46.73 |
| Support Level | $5.83 | $10.13 |
| Resistance Level | $5.97 | $10.69 |
| Average True Range (ATR) | 0.21 | 0.26 |
| MACD | -0.04 | -0.05 |
| Stochastic Oscillator | 34.68 | 46.25 |
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Sky Harbour Group Corp is an aviation infrastructure company focused on building the first nationwide network of Home Base Operator (HBO) campuses designed exclusively for business aircraft. The company develops, leases, and manages general aviation hangars across the United States, targeting airfields in markets with aircraft populations and high hangar demand. Its HBS campuses include private hangars and offer a range of services tailored to aircraft owners operating from these facilities. The majority of the company's revenue is derived from the leasing of home-based aircraft hangars and through services and products ancillary to its leasing activities.